Karp Daniel — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Karp Daniel is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Profile

Karp Daniel

Daniel Karp is an executive known for his role as Executive Vice President of Corporate Development at Organon & Co., a global healthcare company focused on women's health and other critical health issues. He has extensive experience in corporate strategy and development within the pharmaceutical and healthcare sectors.

RoleExecutive VP, Corp. Dev.
Notability60/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-04-02OGNOrganon & Co.F — Tax withholding / forfeiture2.1K$5.70$12K
2026-04-02OGNOrganon & Co.M — Option exercise6.7K$0.00
2026-04-02OGNOrganon & Co.F — Tax withholding / forfeiture3.6K$5.70$20K
2026-04-02OGNOrganon & Co.M — Option exercise11.3K$0.00
2026-03-31OGNOrganon & Co.F — Tax withholding / forfeiture4.4K$5.84$26K
2026-03-31OGNOrganon & Co.M — Option exercise14.2K$0.00

Frequently Asked Questions

Who is Karp Daniel?

Daniel Karp is an executive known for his role as Executive Vice President of Corporate Development at Organon & Co., a global healthcare company focused on women's health and other critical health issues. He has extensive experience in corporate strategy and development within the pharmaceutical and healthcare sectors.…

Where can I see all of Karp Daniel's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Karp Daniel profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.